Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Pharmacodynamic Study of CK-2017357 in Patients With Generalized Myasthenia Gravis

This study has been terminated.
(Closed after complete treatment of 32 patients after 21 months' recruitment.)
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Cytokinetics
ClinicalTrials.gov Identifier:
NCT01268280
First received: December 28, 2010
Last updated: September 16, 2013
Last verified: October 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: October 2012
  Primary Completion Date: October 2012 (Final data collection date for primary outcome measure)